BCAX
Financials
- Market Capitalization 1.54 B
- Employee 103
- Founded 2018
- CEO N/A
- Website www.bicara.com
- Headquarter Delaware, United States
- FIGI BBG00Z15DGK7
- Industry Biotechnology
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 2151 |  AAPG Ascentage Pharma Group International - American Depository Shar | 16.83 USD | -3.50% | -7.98% | -8.13% | -32.68% | 1.57 B USD | ||
| 2163 |  XERS Xeris Biopharma Holdings, Inc. - Common Stock | 8.58 USD | -1.38% | +2.51% | +2.14% | +10.28% | 1.56 B USD | ||
| 2177 |  TYRA Tyra Biosciences, Inc. - Common Stock | 25.50 USD | -2.11% | +0.59% | -17.18% | +77.82% | 1.52 B USD | ||
| 2186 |  LBRX LB Pharmaceuticals Inc - Common Stock | 47.47 USD | -0.31% | +0.15% | +34.78% | +149.84% | 1.53 B USD |
Frequently asked questions about Bicara Therapeutics Inc. Common Stock
What is the Bicara Therapeutics Inc. Common Stock stock price today?
The current price of Bicara Therapeutics Inc. Common Stock (BCAX) is 23.29. Over the past 24 hours, the stock has changed by -2.55%. Follow the BCAX chart for real-time price dynamics.
What is the stock ticker of Bicara Therapeutics Inc. Common Stock?
Bicara Therapeutics Inc. Common Stock trades under the ticker BCAX. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is Bicara Therapeutics Inc. Common Stock stock going up?
BCAX has changed by -4.24% over the last week, -14.88% over the last month, and +61.29% over the last year. Review the chart to see whether the current move is part of a broader trend.
What is the market capitalization of Bicara Therapeutics Inc. Common Stock?
Bicara Therapeutics Inc. Common Stock currently has a market capitalization of 1.54 B. Market capitalization reflects the total market value of a company's outstanding shares and is commonly used to compare companies by size.
What were Bicara Therapeutics Inc. Common Stock earnings last quarter?
Last quarter, Bicara Therapeutics Inc. Common Stock reported earnings of -0.82 per share. Earnings per share is one of the key metrics investors use to evaluate a company's profitability and financial performance.
What was Bicara Therapeutics Inc. Common Stock net income for the last quarter?
Bicara Therapeutics Inc. Common Stock reported net income of -55.44 M for the last quarter. The previous quarter showed -56.21 M, which means net income changed by +1.38%.
How many employees does Bicara Therapeutics Inc. Common Stock have?
As of the latest available data, Bicara Therapeutics Inc. Common Stock has 103 employees. Workforce size can provide additional context about the company's scale and operations.
How can I buy Bicara Therapeutics Inc. Common Stock stock?
You can buy Bicara Therapeutics Inc. Common Stock (BCAX) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in Bicara Therapeutics Inc. Common Stock stock?
Investing in Bicara Therapeutics Inc. Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the BCAX chart and related analysis on metatrader.com as part of your research.